Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Liabilities and Shareholders Equity (2021 - 2026)

Biohaven has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $466.4 million for Q1 2026.

  • Quarterly results put Liabilities and Shareholders Equity at $466.4 million for Q1 2026, up 1.63% from a year ago — trailing twelve months through Mar 2026 was $1.9 billion (down 13.37% YoY), and the annual figure for FY2025 was $451.4 million, down 26.61%.
  • Liabilities and Shareholders Equity reached $466.4 million in Q1 2026 per BHVN's latest filing, up from $451.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $661.8 million in Q4 2022 and bottomed at $135.6 million in Q3 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $506.7 million (2023), compared with a mean of $485.5 million.
  • The largest annual shift saw Liabilities and Shareholders Equity surged 365.84% in 2022 before it crashed 32.33% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $661.8 million in 2022, then dropped by 22.45% to $513.2 million in 2023, then grew by 19.85% to $615.1 million in 2024, then fell by 26.61% to $451.4 million in 2025, then increased by 3.31% to $466.4 million in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for BHVN at $466.4 million in Q1 2026, $451.4 million in Q4 2025, and $409.1 million in Q3 2025.